Zhou XM - Search Results

1

Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery.

Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, Jia JL, Li LM, Mao HL, Zhou XM, Luo H, Gao YF, Xu AG. Zhao YM, et al. Among authors: zhou xm. EClinicalMedicine. 2020 Aug;25:100463. doi: 10.1016/j.eclinm.2020.100463. Epub 2020 Jul 15. EClinicalMedicine. 2020. PMID: 32838236 Free PMC article.

2

A Novel Recombinant Multi-Epitope Vaccine Could Induce Specific Cytotoxic T Lymphocyte Response In Vitro and In Vivo.

Wu Y, Zhai W, Sun M, Zou Z, Zhou X, Li G, Yan Z, Qi Y, Gao Y. Wu Y, et al. Protein Pept Lett. 2017;24(6):573-580. doi: 10.2174/0929866524666170419152700. Protein Pept Lett. 2017. PMID: 28425860

3

Intrinsic Expression of Immune Checkpoint Molecule TIGIT Could Help Tumor Growth in vivo by Suppressing the Function of NK and CD8⁺ T Cells.

Zhou XM, Li WQ, Wu YH, Han L, Cao XG, Yang XM, Wang HF, Zhao WS, Zhai WJ, Qi YM, Gao YF. Zhou XM, et al. Front Immunol. 2018 Nov 29;9:2821. doi: 10.3389/fimmu.2018.02821. eCollection 2018. Front Immunol. 2018. PMID: 30555485 Free PMC article.

4

HLA-A2-Restricted Epitopes Identified from MTA1 Could Elicit Antigen-Specific Cytotoxic T Lymphocyte Response.

Wu Y, Zhai W, Zhou X, Wang Z, Lin Y, Ran L, Qi Y, Gao Y. Wu Y, et al. J Immunol Res. 2018 Nov 25;2018:2942679. doi: 10.1155/2018/2942679. eCollection 2018. J Immunol Res. 2018. PMID: 30596107 Free PMC article.

5

In vitro assay for the development of small molecule inhibitors targeting PD-1/PD-L1.

Zhai W, Zhou X, Du J, Gao Y. Zhai W, et al. Methods Enzymol. 2019;629:361-381. doi: 10.1016/bs.mie.2019.05.051. Epub 2019 Jun 17. Methods Enzymol. 2019. PMID: 31727249

6

Characterization of CD103⁺ CD8⁺ tissue-resident T cells in esophageal squamous cell carcinoma: may be tumor reactive and resurrected by anti-PD-1 blockade.

Han L, Gao QL, Zhou XM, Shi C, Chen GY, Song YP, Yao YJ, Zhao YM, Wen XY, Liu SL, Qi YM, Gao YF. Han L, et al. Among authors: zhou xm. Cancer Immunol Immunother. 2020 Aug;69(8):1493-1504. doi: 10.1007/s00262-020-02562-3. Epub 2020 Apr 13. Cancer Immunol Immunother. 2020. PMID: 32285170 Free PMC article.

7

A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8⁺ T cell responses.

Zhai W, Zhou X, Wang H, Li W, Chen G, Sui X, Li G, Qi Y, Gao Y. Zhai W, et al. Acta Pharm Sin B. 2020 Jun;10(6):1047-1060. doi: 10.1016/j.apsb.2020.01.005. Epub 2020 Jan 13. Acta Pharm Sin B. 2020. PMID: 32642411 Free PMC article.

8

CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy.

Wang H, Sun Y, Zhou X, Chen C, Jiao L, Li W, Gou S, Li Y, Du J, Chen G, Zhai W, Wu Y, Qi Y, Gao Y. Wang H, et al. J Immunother Cancer. 2020 Oct;8(2):e000905. doi: 10.1136/jitc-2020-000905. J Immunother Cancer. 2020. PMID: 33020240 Free PMC article.

9

POTN: A Human Leukocyte Antigen-A2 Immunogenic Peptides Screening Model and Its Applications in Tumor Antigens Prediction.

Meng Q, Wu Y, Sui X, Meng J, Wang T, Lin Y, Wang Z, Zhou X, Qi Y, Du J, Gao Y. Meng Q, et al. Front Immunol. 2020 Oct 7;11:02193. doi: 10.3389/fimmu.2020.02193. eCollection 2020. Front Immunol. 2020. PMID: 33133063 Free PMC article.

10

Identification of CTL Epitopes on Efflux Pumps of the ATP-Binding Cassette and the Major Facilitator Superfamily of Mycobacterium tuberculosis.

Lin Y, Dong Y, Gao Y, Shi R, Li Y, Zhou X, Liu W, Li G, Qi Y, Wu Y. Lin Y, et al. J Immunol Res. 2021 Jan 5;2021:8899674. doi: 10.1155/2021/8899674. eCollection 2021. J Immunol Res. 2021. PMID: 33490292 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

605 results

Search Page